Learn more about the science
Our technology will bring new medicines for diseases of unmet clinical need
Opportunities exist for new therapeutic modalities that can address complex intracellular targets
read moreOur biotransformation toolkit consists of a set of proprietary enzymes performing specific chemistries on a broad range of substrates
read moreProprietary technology leads to Gyrocycle™ highly modified macrocyclic peptides
read moreGyreOx has protected its proprietary technology with four families of patent applications, with some now granted, covering both rationally engineered enzymes and the gyrocycle production process.
read moreGyreOx's technology is based on many years of collaborative research from scientists at the Universities of Oxford, Aberdeen and St Andrews.
read more